'Immunomodulatory' approaches to the management of antiphospholipid syndrome

Rohan Willis, Emilio Gonzalez, Silvia S. Pierangeli

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1-4
Number of pages4
JournalInternational Journal of Clinical Rheumatology
Volume7
Issue number1
DOIs
StatePublished - Feb 2012

Fingerprint

Hydroxychloroquine
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Antiphospholipid Antibodies
Antiphospholipid Syndrome
Rituximab

Keywords

  • antiphospholipid antibodies
  • hydroxychloroquine
  • immunomodulatory
  • management
  • rituximab
  • statins

ASJC Scopus subject areas

  • Rheumatology

Cite this

'Immunomodulatory' approaches to the management of antiphospholipid syndrome. / Willis, Rohan; Gonzalez, Emilio; Pierangeli, Silvia S.

In: International Journal of Clinical Rheumatology, Vol. 7, No. 1, 02.2012, p. 1-4.

Research output: Contribution to journalArticle

@article{abd2bbe8e6c34539bb069868ba05b95e,
title = "'Immunomodulatory' approaches to the management of antiphospholipid syndrome",
keywords = "antiphospholipid antibodies, hydroxychloroquine, immunomodulatory, management, rituximab, statins",
author = "Rohan Willis and Emilio Gonzalez and Pierangeli, {Silvia S.}",
year = "2012",
month = "2",
doi = "10.2217/ijr.11.77",
language = "English (US)",
volume = "7",
pages = "1--4",
journal = "Future Rheumatology",
issn = "1758-4272",
publisher = "Future Medicine Ltd.",
number = "1",

}

TY - JOUR

T1 - 'Immunomodulatory' approaches to the management of antiphospholipid syndrome

AU - Willis, Rohan

AU - Gonzalez, Emilio

AU - Pierangeli, Silvia S.

PY - 2012/2

Y1 - 2012/2

KW - antiphospholipid antibodies

KW - hydroxychloroquine

KW - immunomodulatory

KW - management

KW - rituximab

KW - statins

UR - http://www.scopus.com/inward/record.url?scp=84856638474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856638474&partnerID=8YFLogxK

U2 - 10.2217/ijr.11.77

DO - 10.2217/ijr.11.77

M3 - Article

VL - 7

SP - 1

EP - 4

JO - Future Rheumatology

JF - Future Rheumatology

SN - 1758-4272

IS - 1

ER -